Scinovex
articleTop 1% cited

SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION

Transplantation · 1999 · Vol. 67(7) · pp. 1036–1042

Abstract

Results at 12 months suggest that sirolimus can be used as base therapy in the prophylaxis of acute renal transplant rejection, and has a safety profile that differs from CsA.

Renal Transplantation Outcomes and TreatmentsOral and gingival health researchNeurological Complications and SyndromesSirolimusMedicineGastroenterologyTransplantationUrologyAzathioprineInternal medicineTrough levelTacrolimusSurgery

MeSH terms

AdultAgedFemaleHumansImmunosuppressive AgentsKidneyMaleMiddle AgedOsmolar ConcentrationPatient DropoutsPilot ProjectsKidney TransplantationCyclosporineTreatment OutcomeSirolimus
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION · Scinovex